Skip to main
BEAT

HeartBeam (BEAT) Stock Forecast & Price Target

HeartBeam (BEAT) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartBeam Inc. is positioned favorably within the burgeoning mobile ECG devices market, which is projected to expand from a valuation of $4.1 billion in 2024 to $8.9 billion by 2032, driven by increasing incidences of cardiac disease and the demand for remote diagnosis solutions. The company’s proprietary Vector Electrocardiography (VECG) technology platform has demonstrated high sensitivity (92-100%) and improved specificity (54-58%), which enhances the potential for FDA clearance and market adoption. Furthermore, with a target market of 2.6 million elevated-risk patients and potential annual revenue ranging from $1.3 billion to $2.6 billion, HeartBeam's growth prospects are bolstered by an anticipated shift towards reimbursement-driven revenue models and the expansion of patient subscription services.

Bears say

HeartBeam Inc faces significant challenges that contribute to a negative outlook on its stock, primarily stemming from potential reimbursement issues that could limit product demand and adversely affect revenue. The company’s product performance metrics indicate limitations in accuracy, particularly highlighted by its lower area under curve (AUC) values in “spot” mode, which could undermine its competitive edge in cardiac monitoring. Additionally, the auditors’ going-concern opinion raises substantial doubts regarding the company’s financial viability without new funding, suggesting that ongoing negative cash flows may persist into 2025 and 2026, further complicating its operational stability and investor confidence.

HeartBeam (BEAT) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartBeam and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartBeam (BEAT) Forecast

Analysts have given HeartBeam (BEAT) a Strong Buy based on their latest research and market trends.

According to 2 analysts, HeartBeam (BEAT) has a Strong Buy consensus rating as of Dec 28, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartBeam (BEAT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.